The Cardinal Wyszynski Institute of Cardiology has begun collaborating with the ISMETT clinic (Mediterranean Institute for Transplantation and Advanced Specialized Therapies) in Palermo on the development of the Remedizer software. This application monitors the health status of patients with implanted left ventricular assist devices (LVADs) after completing hospitalization. Cooperation with the Italian clinic aims to extend the application, created with the contribution of the Institute of Cardiology, to include new groups of chronically ill patients.
It has been two years since the Polish launch of a large scale research project set to determine the role of early invasive diagnostics and coronary revascularization in patients with stable coronary artery disease and significant myocardial ischemia on stress testing. The ISCHEMIA Trial is one or the largest multinational, randomized trial sponsored by the American National Heart, Lung, and Blood Institute (NHLBI).
On 1 Jan 2015, it has been five years since the Institute of Cardiology Unit for Screening Studies in Inherited Cardiovascular Diseases (USSICD) was established. Since 19 Mar 2014 the USSICD has been operating in its own separate location. There are 2147 patients and their relatives registered in the Unit. The largest groups of patients and their relatives with dilated cardiomyopathy (n=616), with aneurysm and thoracic aortic dissection (n=520), and other cardiomyopathies (n=306).
We wish to inform you that the Unit for Screening Studies in Inherited Cardiovascular Diseases (USS-ICVD), which has been functioning since the 1st of January 2010, has been transferred to a new location. The place looks modern and adheres to high standards that meet all relevant EU recommendations for health care facilities.
A modern, fully equipped hybrid operating room has been launched at the Institute of Cardiology, Warsaw.
A hybrid room is a platform of cooperation between interventional cardiologists and cardiosurgeons. It enables a multidisciplinary Heart Team to treat simultaneously the heart and large vessels. Such an approach is recommended by both the European Society of Cardiology and the Polish Cardiac Society.